{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:41:45Z","timestamp":1786995705775,"version":"build-2736575974"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.phrs.2024.107515","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T12:48:49Z","timestamp":1732106929000},"page":"107515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["PPAR\u03b2\/\u03b4 prevents inflammation and fibrosis during diabetic cardiomyopathy"],"prefix":"10.1016","volume":"210","author":[{"given":"Adel","family":"Rostami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Palomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pizarro-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Valenzuela-Alcaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1tima","family":"Crispi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Francisco","family":"Nistal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A.","family":"Hurl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Wahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"V\u00e1zquez-Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.phrs.2024.107515_bib1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.phrs.2024.107515_bib2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2337\/diacare.28.3.612","article-title":"The association between glucose abnormalities and heart failure in the population-based Reykjavik study","volume":"28","author":"Thrainsdottir","year":"2005","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.phrs.2024.107515_bib3","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3904\/kjim.2016.208","article-title":"Diabetic cardiomyopathy: where we are and where we are going","volume":"32","author":"Lee","year":"2017","journal-title":"Korean J. Intern Med"},{"issue":"9626","key":"10.1016\/j.phrs.2024.107515_bib4","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/S0140-6736(08)60767-9","article-title":"Type 1 diabetes, hyperglycaemia, and the heart","volume":"371","author":"Retnakaran","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.phrs.2024.107515_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tips.2018.02.010","article-title":"Emerging actors in diabetic cardiomyopathy: heartbreaker biomarkers or therapeutic targets?","volume":"39","author":"Palomer","year":"2018","journal-title":"Trends Pharm. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2024.107515_bib6","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","article-title":"An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy","volume":"168","author":"Palomer","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"22","key":"10.1016\/j.phrs.2024.107515_bib7","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.jacc.2008.07.062","article-title":"Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus","volume":"52","author":"Rijzewijk","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.phrs.2024.107515_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/652097","article-title":"Potential role of nuclear factor kappaB in diabetic cardiomyopathy","volume":"2011","author":"Lorenzo","year":"2011","journal-title":"Mediat. Inflamm."},{"issue":"7","key":"10.1016\/j.phrs.2024.107515_bib9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.112.094524","article-title":"MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene\/transforming growth factor-beta1 pathway","volume":"126","author":"Pan","year":"2012","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.phrs.2024.107515_bib10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1042\/CS20080500","article-title":"Diabetic cardiomyopathy","volume":"116","author":"Asghar","year":"2009","journal-title":"Clin. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvr212","article-title":"Lipotoxicity in type 2 diabetic cardiomyopathy","volume":"92","author":"van de Weijer","year":"2011","journal-title":"Cardiovasc Res."},{"issue":"5","key":"10.1016\/j.phrs.2024.107515_bib12","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.yjmcc.2004.07.008","article-title":"Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats","volume":"37","author":"Fiordaliso","year":"2004","journal-title":"J. Mol. Cell Cardiol."},{"issue":"9","key":"10.1016\/j.phrs.2024.107515_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/CIRCULATIONAHA.115.015357","article-title":"Diabetic cardiomyopathy: catabolism driving metabolism","volume":"131","author":"Wang","year":"2015","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.phrs.2024.107515_bib14","doi-asserted-by":"crossref","first-page":"17464","DOI":"10.1074\/jbc.M414220200","article-title":"Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy","volume":"280","author":"Planavila","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2024.107515_bib15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.cardiores.2004.11.011","article-title":"M. V\u00e1zquez-Carrera, Peroxisome proliferator-activated receptor beta\/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes","volume":"65","author":"Planavila","year":"2005","journal-title":"Cardiovasc Res."},{"issue":"2","key":"10.1016\/j.phrs.2024.107515_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.plipres.2005.12.002","article-title":"From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions","volume":"45","author":"Feige","year":"2006","journal-title":"Prog. Lipid Res."},{"issue":"49","key":"10.1016\/j.phrs.2024.107515_bib17","doi-asserted-by":"crossref","first-page":"35372","DOI":"10.1074\/jbc.M113.507426","article-title":"Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C signaling","volume":"288","author":"Verma","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib18","doi-asserted-by":"crossref","first-page":"F214","DOI":"10.1152\/ajprenal.00204.2005","article-title":"Impact of genetic background on nephropathy in diabetic mice","volume":"290","author":"Gurley","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107515_bib19","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1210\/en.2010-1468","article-title":"The PPAR{beta}\/{delta} activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1{alpha}-Lipin 1-PPAR{alpha} pathway leading to increased fatty acid oxidation","volume":"152","author":"Barroso","year":"2011","journal-title":"Endocrinology"},{"issue":"13","key":"10.1016\/j.phrs.2024.107515_bib20","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.phrs.2024.107515_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41392-020-0114-1","article-title":"SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation","volume":"5","author":"Palomer","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"issue":"6","key":"10.1016\/j.phrs.2024.107515_bib22","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.ijcard.2012.06.006","article-title":"Resveratrol induces nuclear factor-kappaB activity in human cardiac cells","volume":"167","author":"Palomer","year":"2013","journal-title":"Int J. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/cvr\/cvn172","article-title":"Decrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic rats","volume":"80","author":"Yu","year":"2008","journal-title":"Cardiovasc Res."},{"issue":"3","key":"10.1016\/j.phrs.2024.107515_bib24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/db10-1361","article-title":"Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice","volume":"60","author":"Matsushita","year":"2011","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib25","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1038\/s41598-018-20703-8","article-title":"Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia","volume":"8","author":"Chandramouli","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.phrs.2024.107515_bib26","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic Mechanisms of Diabetic Heart Disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res"},{"issue":"6","key":"10.1016\/j.phrs.2024.107515_bib27","doi-asserted-by":"crossref","first-page":"H1552","DOI":"10.1152\/ajpheart.00182.2019","article-title":"A novel method optimizing the normalization of cardiac parameters in small animal models: the importance of dimensional indexing","volume":"316","author":"Hagdorn","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2024.107515_bib28","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107515_bib29","doi-asserted-by":"crossref","first-page":"H1036","DOI":"10.1152\/ajpheart.00340.2014","article-title":"Cardiac-specific suppression of NF-kappaB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system","volume":"307","author":"Thomas","year":"2014","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"11","key":"10.1016\/j.phrs.2024.107515_bib30","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.2337\/db11-0549","article-title":"TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat model","volume":"60","author":"Ti","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2024.107515_bib31","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mad.2016.11.005","article-title":"New mechanism of lipotoxicity in diabetic cardiomyopathy: deficiency of endogenous H2S production and ER stress","volume":"162","author":"Guo","year":"2017","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.phrs.2024.107515_bib32","first-page":"3764370","article-title":"Dihydromyricetin protects against diabetic cardiomyopathy in streptozotocin-induced diabetic mice","volume":"2017","author":"Wu","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.phrs.2024.107515_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.705154","article-title":"Weighted gene Co-expression network analysis identifies ANGPTL4 as a key regulator in diabetic cardiomyopathy via FAK\/SIRT3\/ROS pathway in cardiomyocyte","volume":"12","author":"Dai","year":"2021","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.phrs.2024.107515_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150336","article-title":"Small extracellular vesicles associated miRNA in myocardial fibrosis","volume":"727","author":"Long","year":"2024","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.phrs.2024.107515_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.14740\/cr1467","article-title":"Immobilizing interstitial cardiac fibrosis","volume":"14","author":"Shevchenko","year":"2023","journal-title":"Cardiol. Res."},{"key":"10.1016\/j.phrs.2024.107515_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113904","article-title":"Fibrosis of the diabetic heart: clinical significance, molecular mechanisms, and therapeutic opportunities","volume":"176","author":"Tuleta","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2024.107515_bib37","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1111\/j.1742-4658.2009.07039.x","article-title":"The IkappaBalpha gene is a peroxisome proliferator-activated receptor cardiac target gene","volume":"276","author":"Buroker","year":"2009","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.phrs.2024.107515_bib38","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.bbalip.2016.01.019","article-title":"PPARbeta\/delta and lipid metabolism in the heart","volume":"1861","author":"Palomer","year":"2016","journal-title":"Biochim Biophys. Acta"},{"issue":"4","key":"10.1016\/j.phrs.2024.107515_bib39","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.cardiores.2004.11.011","article-title":"Peroxisome proliferator-activated receptor beta\/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes","volume":"65","author":"Planavila","year":"2005","journal-title":"Cardiovasc Res."},{"issue":"17","key":"10.1016\/j.phrs.2024.107515_bib40","doi-asserted-by":"crossref","first-page":"17464","DOI":"10.1074\/jbc.M414220200","article-title":"Nuclear factor-kappaB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy","volume":"280","author":"Planavila","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.bbalip.2010.11.002","article-title":"PPARbeta\/delta activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells","volume":"1811","author":"\u00c1lvarez-Guardia","year":"2011","journal-title":"Biochim Biophys. Acta"},{"issue":"5","key":"10.1016\/j.phrs.2024.107515_bib42","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/jcb.21197","article-title":"Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy","volume":"100","author":"Li","year":"2007","journal-title":"J. Cell Biochem."},{"issue":"3","key":"10.1016\/j.phrs.2024.107515_bib43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00125-011-2401-4","article-title":"The peroxisome proliferator-activated receptor (PPAR) beta\/delta agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells","volume":"55","author":"Serrano-Marco","year":"2012","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.phrs.2024.107515_bib44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41419-017-0093-5","article-title":"Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis","volume":"9","author":"Gu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.phrs.2024.107515_bib45","first-page":"1081","article-title":"miR-146a targets c-Fos expression in human cardiac cells","volume":"8","author":"Palomer","year":"2015","journal-title":"Dis. Model Mech."},{"issue":"8","key":"10.1016\/j.phrs.2024.107515_bib46","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.febslet.2006.02.056","article-title":"Glycogen synthase kinase 3beta together with 14-3-3 protein regulates diabetic cardiomyopathy: effect of losartan and tempol","volume":"580","author":"Gurusamy","year":"2006","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.phrs.2024.107515_bib47","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1159\/000335805","article-title":"Depletion of 14-3-3 protein exacerbates cardiac oxidative stress, inflammation and remodeling process via modulation of MAPK\/NF-kB signaling pathways after streptozotocin-induced diabetes mellitus","volume":"28","author":"Thandavarayan","year":"2011","journal-title":"Cell Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.phrs.2024.107515_bib48","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1159\/000494576","article-title":"LncRNA KCNQ1OT1 mediates pyroptosis in diabetic cardiomyopathy","volume":"50","author":"Yang","year":"2018","journal-title":"Cell Physiol. Biochem"},{"issue":"7","key":"10.1016\/j.phrs.2024.107515_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067009","article-title":"Multiple antioxidants improve cardiac complications and inhibit cardiac cell death in streptozotocin-induced diabetic rats","volume":"8","author":"Kumar","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2024.107515_bib50","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003804","article-title":"Plasma and cardiac galectin-3 in patients with heart failure reflects both inflammation and fibrosis: implications for its use as a biomarker","volume":"10","author":"Besler","year":"2017","journal-title":"Circ. Heart Fail"},{"issue":"1-2","key":"10.1016\/j.phrs.2024.107515_bib51","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12026-012-8286-6","article-title":"The roles of Galectin-3 in autoimmunity and tumor progression","volume":"52","author":"Radosavljevic","year":"2012","journal-title":"Immunol. Res."},{"issue":"9","key":"10.1016\/j.phrs.2024.107515_bib52","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1161\/CIRCULATIONAHA.114.012285","article-title":"Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor alpha","volume":"131","author":"Liu","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.phrs.2024.107515_bib53","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.yexcr.2017.12.007","article-title":"Potential role of MG53 in the regulation of transforming-growth-factor-beta1-induced atrial fibrosis and vulnerability to atrial fibrillation","volume":"362","author":"Guo","year":"2018","journal-title":"Exp. Cell Res."},{"issue":"10","key":"10.1016\/j.phrs.2024.107515_bib54","doi-asserted-by":"crossref","first-page":"17749","DOI":"10.1002\/jcp.28400","article-title":"TRIM72 contributes to cardiac fibrosis via regulating STAT3\/Notch-1 signaling","volume":"234","author":"Chen","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"12","key":"10.1016\/j.phrs.2024.107515_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189330","article-title":"Rev-erb agonist improves adverse cardiac remodeling and survival in myocardial infarction through an anti-inflammatory mechanism","volume":"12","author":"Stujanna","year":"2017","journal-title":"PLoS One"},{"issue":"17","key":"10.1016\/j.phrs.2024.107515_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.95177","article-title":"REV-ERBalpha ameliorates heart failure through transcription repression","volume":"2","author":"Zhang","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.phrs.2024.107515_bib57","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cardiores.2007.04.026","article-title":"Activation of PPARdelta inhibits cardiac fibroblast proliferation and the transdifferentiation into myofibroblasts","volume":"75","author":"Teunissen","year":"2007","journal-title":"Cardiovasc Res."},{"issue":"12","key":"10.1016\/j.phrs.2024.107515_bib58","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.005962","article-title":"Collaborative Regulation of LRG1 by TGF-beta1 and PPAR-beta\/delta modulates chronic pressure overload-induced cardiac fibrosis","volume":"12","author":"Liu","year":"2019","journal-title":"Circ. Heart Fail"},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s43044-023-00376-z","article-title":"Potential molecular mechanism underlying cardiac fibrosis in diabetes mellitus: a narrative review","volume":"75","author":"Ridwan","year":"2023","journal-title":"Egypt Heart J."},{"issue":"4","key":"10.1016\/j.phrs.2024.107515_bib60","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jdi.13329","article-title":"Sodium-glucose cotransporter 2 inhibitors represent a paradigm shift in the prevention of heart failure in type 2 diabetes patients","volume":"12","author":"Kashiwagi","year":"2021","journal-title":"J. Diabetes Invest."},{"issue":"3","key":"10.1016\/j.phrs.2024.107515_bib62","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1530\/JOE-19-0058","article-title":"Inhibition of EGFR-STAT3 attenuates cardiomyopathy in streptozotocin-induced type 1 diabetes","volume":"242","author":"Luo","year":"2019","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.phrs.2024.107515_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154987","article-title":"beta-elemene alleviates hyperglycemia-induced cardiac inflammation and remodeling by inhibiting the JAK\/STAT3-NF-kappaB pathway","volume":"119","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2024.107515_bib64","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.fct.2013.11.013","article-title":"Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis","volume":"63","author":"Sun","year":"2014","journal-title":"Food Chem. Toxicol."},{"issue":"7","key":"10.1016\/j.phrs.2024.107515_bib65","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.3390\/ijms18071364","article-title":"Ginsenoside Rh2 Improves Cardiac Fibrosis via PPARdelta-STAT3 Signaling in Type 1-Like Diabetic Rats","volume":"18","author":"Lo","year":"2017","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2024.107515_bib66","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1159\/000354499","article-title":"STAT1\/3 and ERK1\/2 synergistically regulate cardiac fibrosis induced by high glucose","volume":"32","author":"Dai","year":"2013","journal-title":"Cell Physiol. Biochem"},{"issue":"4","key":"10.1016\/j.phrs.2024.107515_bib67","first-page":"205","article-title":"Interaction of AP-1 and the ctgf gene: a possible driver of chondrocyte hypertrophy in growth cartilage","volume":"21","author":"Moritani","year":"2003","journal-title":"J. Bone Min. Metab."},{"issue":"11","key":"10.1016\/j.phrs.2024.107515_bib68","doi-asserted-by":"crossref","first-page":"9532","DOI":"10.1002\/jcb.27270","article-title":"GW0742 activates peroxisome proliferator-activated receptor delta to reduce free radicals and alleviate cardiac hypertrophy induced by hyperglycemia in cultured H9c2 cells","volume":"119","author":"Cheng","year":"2018","journal-title":"J. Cell Biochem"},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib69","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12933-016-0430-5","article-title":"Telmisartan improves cardiac fibrosis in diabetes through peroxisome proliferator activated receptor delta (PPARdelta): from bedside to bench","volume":"15","author":"Chang","year":"2016","journal-title":"Cardiovasc Diabetol."},{"issue":"1-2","key":"10.1016\/j.phrs.2024.107515_bib70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejps.2011.03.011","article-title":"Peroxisome proliferator-activated receptor delta downregulates the expression of the receptor for advanced glycation end products and pro-inflammatory cytokines in the kidney of streptozotocin-induced diabetic mice","volume":"43","author":"Liang","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1124\/mol.53.1.14","article-title":"Peroxisome proliferator activated receptor-alpha expression in human liver","volume":"53","author":"Palmer","year":"1998","journal-title":"Mol. Pharm."},{"issue":"34","key":"10.1016\/j.phrs.2024.107515_bib72","doi-asserted-by":"crossref","first-page":"31521","DOI":"10.1074\/jbc.M103306200","article-title":"Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) alpha. PPAR alpha fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expresson","volume":"276","author":"Lawrence","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2024.107515_bib73","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-012-9313-3","article-title":"Diabetic cardiomyopathy: pathophysiology and clinical features","volume":"18","author":"Miki","year":"2013","journal-title":"Heart Fail Rev."},{"issue":"8","key":"10.1016\/j.phrs.2024.107515_bib74","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.bbadis.2016.10.021","article-title":"Sirt3 deficiency exacerbates diabetic cardiac dysfunction: role of Foxo3A-Parkin-mediated mitophagy","volume":"1863","author":"Yu","year":"2017","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.phrs.2024.107515_bib75","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.3389\/fimmu.2018.03083","article-title":"The C\/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection","volume":"9","author":"Hu","year":"2018","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2024.107515_bib76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvx011","article-title":"An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy","volume":"113","author":"Frati","year":"2017","journal-title":"Cardiovasc Res."},{"issue":"8","key":"10.1016\/j.phrs.2024.107515_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042721","article-title":"Stress-inducible caspase substrate TRB3 promotes nuclear translocation of procaspase-3","volume":"7","author":"Shimizu","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib78","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3164\/jcbn.2007008","article-title":"Involvement of endoplasmic reticulum stress in myocardial apoptosis of streptozocin-induced diabetic rats","volume":"41","author":"Li","year":"2007","journal-title":"J. Clin. Biochem Nutr."},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib79","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/cvr\/cvq274","article-title":"Cardiomyocyte NF-kappaB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure","volume":"89","author":"Hamid","year":"2011","journal-title":"Cardiovasc Res."},{"issue":"5","key":"10.1016\/j.phrs.2024.107515_bib80","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.yjmcc.2012.08.013","article-title":"Diabetes triggers a PARP1 mediated death pathway in the heart through participation of FoxO1","volume":"53","author":"Puthanveetil","year":"2012","journal-title":"J. Mol. Cell Cardiol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107515_bib81","doi-asserted-by":"crossref","first-page":"C422","DOI":"10.1152\/ajpcell.00577.2001","article-title":"High glucose inhibits apoptosis in human coronary artery smooth muscle cells by increasing bcl-xL and bfl-1\/A1","volume":"283","author":"Sakuma","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib82","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/JOE-17-0681","article-title":"Isosteviol ameliorates diabetic cardiomyopathy in rats by inhibiting ERK and NF-kappaB signaling pathways","volume":"238","author":"Tang","year":"2018","journal-title":"J. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2024.107515_bib83","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/jcp.27070","article-title":"Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy","volume":"234","author":"Zuo","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.phrs.2024.107515_bib84","first-page":"5582567","article-title":"FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model","author":"Wang","year":"2021","journal-title":"Evid. Based Complement Altern. Med.\u00a02021"},{"key":"10.1016\/j.phrs.2024.107515_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116413","article-title":"Targeting MAPK-ERK\/JNK pathway: a potential intervention mechanism of myocardial fibrosis in heart failure","volume":"173","author":"Zhang","year":"2024","journal-title":"Biomed. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2024.107515_bib86","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"2","key":"10.1016\/j.phrs.2024.107515_bib87","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13577-020-00430-x","article-title":"SH2 domain-containing protein tyrosine phosphatase-2 (SHP-2) prevents cardiac remodeling after myocardial infarction through ERK\/SMAD signaling pathway","volume":"34","author":"Lu","year":"2021","journal-title":"Hum. Cell"},{"issue":"17","key":"10.1016\/j.phrs.2024.107515_bib88","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179636","article-title":"MicroRNA Let-7a, -7e and -133a attenuate hypoxia-induced atrial fibrosis via targeting collagen expression and the JNK pathway in HL1 cardiomyocytes","volume":"23","author":"Lo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107515_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2023.165500","article-title":"Dibutyl phthalate induces liver fibrosis via p38MAPK\/NF-kappaB\/NLRP3-mediated pyroptosis","volume":"897","author":"Huo","year":"2023","journal-title":"Sci. Total Environ."},{"issue":"4","key":"10.1016\/j.phrs.2024.107515_bib90","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nbt0411-301","article-title":"p38 kinase inhibitor approved for idiopathic pulmonary fibrosis","volume":"29","author":"Moran","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"11","key":"10.1016\/j.phrs.2024.107515_bib91","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.21037\/jtd-23-780","article-title":"PM2.5 induces lung inflammation and fibrosis via airway smooth muscle cell expression of the Wnt5a\/JNK pathway","volume":"15","author":"Zou","year":"2023","journal-title":"J. Thorac. Dis."},{"issue":"23","key":"10.1016\/j.phrs.2024.107515_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239084","article-title":"TGF-beta Induced CTGF expression in human lung epithelial cells through ERK, ADAM17, RSK1, and C\/EBPbeta pathways","volume":"21","author":"Ou","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.phrs.2024.107515_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115935","article-title":"Alpha-mangostin alleviate renal interstitial fibrosis via suppression of TGF-beta1\/Smad\/ERK signaling axis in vitro and in vivo","volume":"218","author":"Juan","year":"2023","journal-title":"Biochem Pharm."},{"key":"10.1016\/j.phrs.2024.107515_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120092","article-title":"ERK and p38 MAPK inhibition controls NF-E2 degradation and profibrotic signaling in renal proximal tubule cells","volume":"287","author":"Li","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2024.107515_bib95","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.matbio.2022.03.008","article-title":"Activation of the ATX\/LPA\/LPARs axis induces a fibrotic response in skeletal muscle","volume":"109","author":"Cordova-Casanova","year":"2022","journal-title":"Matrix Biol."},{"issue":"5","key":"10.1016\/j.phrs.2024.107515_bib96","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.tcb.2013.11.008","article-title":"Succinate: a metabolic signal in inflammation","volume":"24","author":"Mills","year":"2014","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.phrs.2024.107515_bib97","article-title":"SGLT1 Inhibition attenuates apoptosis in diabetic cardiomyopathy via the JNK and p38 pathway","volume":"11","author":"Lin","year":"2020","journal-title":"Front Pharm."},{"issue":"12","key":"10.1016\/j.phrs.2024.107515_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122001","article-title":"The Role of ERK1\/2 in the development of diabetic cardiomyopathy","volume":"17","author":"Xu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2024.107515_bib99","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00125-017-4469-y","article-title":"Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes","volume":"61","author":"Purvis","year":"2018","journal-title":"Diabetologia"},{"issue":"1-2","key":"10.1016\/j.phrs.2024.107515_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-016-2838-3","article-title":"MicroRNA-200c modulates DUSP-1 expression in diabetes-induced cardiac hypertrophy","volume":"424","author":"Singh","year":"2017","journal-title":"Mol. Cell Biochem."},{"issue":"3","key":"10.1016\/j.phrs.2024.107515_bib101","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/cvr\/cvab120","article-title":"Concurrent diabetes and heart failure: interplay and novel therapeutic approaches","volume":"118","author":"Karwi","year":"2022","journal-title":"Cardiovasc Res."},{"issue":"24","key":"10.1016\/j.phrs.2024.107515_bib102","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.3390\/ijms21249577","article-title":"Comparison of PPAR ligands as modulators of resolution of inflammation, via their influence on cytokines and oxylipins release in astrocytes","volume":"21","author":"Chistyakov","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661824004602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T06:48:58Z","timestamp":1734504538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661824004602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":102,"alternative-id":["S1043661824004602"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107515","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PPAR\u03b2\/\u03b4 prevents inflammation and fibrosis during diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2024.107515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107515"}}